?>
Logo

BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 401k Plan overview

Plan NameBIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN
Plan identification number 001

BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Participant-directed brokerage accounts provided as an investment option under the plan.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Plan covering Self-Employed individuals.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC has sponsored the creation of one or more 401k plans.

Company Name:BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC
Employer identification number (EIN):522170293
NAIC Classification:621111
NAIC Description:Offices of Physicians (except Mental Health Specialists)

Form 5500 Filing Information

Submission information for form 5500 for 401k plan BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012022-01-01
0012021-01-01
0012020-01-01
0012019-01-01
0012018-01-01
0012017-01-01CHRIS BARNES
0012016-01-01CHRIS BARNES
0012015-01-01CHRIS BARNES
0012014-01-01CHRIS BARNES
0012013-01-01JAMES CANTRELL
0012012-01-01JAMES CANTRELL
0012011-01-01JAMES CANTRELL
0012009-01-01JAMES CANTRELL
0012009-01-01JAMES CANTRELL

Plan Statistics for BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN

401k plan membership statisitcs for BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN

Measure Date Value
2022: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-01281
Total number of active participants reported on line 7a of the Form 55002022-01-01234
Number of retired or separated participants receiving benefits2022-01-0132
Number of other retired or separated participants entitled to future benefits2022-01-0166
Total of all active and inactive participants2022-01-01332
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-010
Total participants2022-01-01332
Number of participants with account balances2022-01-01318
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-0122
2021: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-01242
Total number of active participants reported on line 7a of the Form 55002021-01-01225
Number of other retired or separated participants entitled to future benefits2021-01-0148
Total of all active and inactive participants2021-01-01273
Total participants2021-01-01273
Number of participants with account balances2021-01-01273
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-0123
2020: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-01248
Total number of active participants reported on line 7a of the Form 55002020-01-01222
Number of other retired or separated participants entitled to future benefits2020-01-0120
Total of all active and inactive participants2020-01-01242
Total participants2020-01-01242
Number of participants with account balances2020-01-01242
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-0139
2019: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-01233
Total number of active participants reported on line 7a of the Form 55002019-01-01188
Number of retired or separated participants receiving benefits2019-01-0120
Number of other retired or separated participants entitled to future benefits2019-01-0139
Total of all active and inactive participants2019-01-01247
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-011
Total participants2019-01-01248
Number of participants with account balances2019-01-01246
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-0113
2018: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-01201
Total number of active participants reported on line 7a of the Form 55002018-01-01178
Number of retired or separated participants receiving benefits2018-01-0110
Number of other retired or separated participants entitled to future benefits2018-01-0128
Total of all active and inactive participants2018-01-01216
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-011
Total participants2018-01-01217
Number of participants with account balances2018-01-01213
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-016
2017: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-01191
Total number of active participants reported on line 7a of the Form 55002017-01-01169
Number of retired or separated participants receiving benefits2017-01-015
Number of other retired or separated participants entitled to future benefits2017-01-0119
Total of all active and inactive participants2017-01-01193
Total participants2017-01-01193
Number of participants with account balances2017-01-01182
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-012
2016: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-01182
Total number of active participants reported on line 7a of the Form 55002016-01-01159
Number of retired or separated participants receiving benefits2016-01-014
Number of other retired or separated participants entitled to future benefits2016-01-0123
Total of all active and inactive participants2016-01-01186
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-010
Total participants2016-01-01186
Number of participants with account balances2016-01-01180
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-012
2015: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-01169
Total number of active participants reported on line 7a of the Form 55002015-01-01156
Number of retired or separated participants receiving benefits2015-01-015
Number of other retired or separated participants entitled to future benefits2015-01-0121
Total of all active and inactive participants2015-01-01182
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-010
Total participants2015-01-01182
Number of participants with account balances2015-01-01139
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-010
2014: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-01174
Total number of active participants reported on line 7a of the Form 55002014-01-01142
Number of retired or separated participants receiving benefits2014-01-019
Number of other retired or separated participants entitled to future benefits2014-01-0118
Total of all active and inactive participants2014-01-01169
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-010
Total participants2014-01-01169
Number of participants with account balances2014-01-01129
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-012
2013: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-01162
Total number of active participants reported on line 7a of the Form 55002013-01-01152
Number of retired or separated participants receiving benefits2013-01-011
Number of other retired or separated participants entitled to future benefits2013-01-0121
Total of all active and inactive participants2013-01-01174
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-010
Total participants2013-01-01174
Number of participants with account balances2013-01-01159
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-010
2012: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-01154
Total number of active participants reported on line 7a of the Form 55002012-01-01139
Number of other retired or separated participants entitled to future benefits2012-01-0123
Total of all active and inactive participants2012-01-01162
Total participants2012-01-01162
Number of participants with account balances2012-01-01145
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-013
2011: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-01145
Total number of active participants reported on line 7a of the Form 55002011-01-01129
Number of retired or separated participants receiving benefits2011-01-016
Number of other retired or separated participants entitled to future benefits2011-01-0119
Total of all active and inactive participants2011-01-01154
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01154
Number of participants with account balances2011-01-01140
2009: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-01125
Total number of active participants reported on line 7a of the Form 55002009-01-01105
Number of retired or separated participants receiving benefits2009-01-014
Number of other retired or separated participants entitled to future benefits2009-01-0125
Total of all active and inactive participants2009-01-01134
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01134
Number of participants with account balances2009-01-01123
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-010

Financial Data on BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN

Measure Date Value
2022 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2022 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2022-12-31$-7,569,767
Total unrealized appreciation/depreciation of assets2022-12-31$-7,569,767
Total income from all sources (including contributions)2022-12-31$-3,706,825
Total of all expenses incurred2022-12-31$1,107,391
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$1,026,528
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$2,388,648
Value of total assets at end of year2022-12-31$37,153,414
Value of total assets at beginning of year2022-12-31$41,967,630
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$80,863
Total interest from all sources2022-12-31$1,474,294
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$500,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$1,020,959
Participant contributions at end of year2022-12-31$0
Participant contributions at beginning of year2022-12-31$15,895
Assets. Other investments not covered elsewhere at end of year2022-12-31$7,988,112
Assets. Other investments not covered elsewhere at beginning of year2022-12-31$9,037,618
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-4,814,216
Value of net assets at end of year (total assets less liabilities)2022-12-31$37,153,414
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$41,967,630
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Assets. partnership/joint venture interests at end of year2022-12-31$0
Assets. partnership/joint venture interests at beginning of year2022-12-31$134,672
Investment advisory and management fees2022-12-31$80,863
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$26,918,149
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$30,816,599
Interest earned on other investments2022-12-31$1,474,294
Value of interest in common/collective trusts at end of year2022-12-31$879,464
Value of interest in common/collective trusts at beginning of year2022-12-31$730,305
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31Yes
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$1,367,689
Employer contributions (assets) at end of year2022-12-31$1,367,689
Employer contributions (assets) at beginning of year2022-12-31$1,232,541
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$1,026,528
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32022-12-31No
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31BLACK & PINCKARD, LLC
Accountancy firm EIN2022-12-31260079381
2021 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2021 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2021-12-31$2,924,899
Total unrealized appreciation/depreciation of assets2021-12-31$2,924,899
Total income from all sources (including contributions)2021-12-31$7,358,307
Total of all expenses incurred2021-12-31$3,243,885
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$3,165,033
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$2,210,297
Value of total assets at end of year2021-12-31$41,967,630
Value of total assets at beginning of year2021-12-31$37,853,208
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$78,852
Total interest from all sources2021-12-31$2,223,111
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$2,064,053
If this is an individual account plan, was there a blackout period2021-12-31No
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$974,580
Participant contributions at end of year2021-12-31$15,895
Participant contributions at beginning of year2021-12-31$16,090
Assets. Other investments not covered elsewhere at end of year2021-12-31$9,037,618
Assets. Other investments not covered elsewhere at beginning of year2021-12-31$8,141,541
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$3,176
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$4,114,422
Value of net assets at end of year (total assets less liabilities)2021-12-31$41,967,630
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$37,853,208
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Assets. partnership/joint venture interests at end of year2021-12-31$134,672
Assets. partnership/joint venture interests at beginning of year2021-12-31$2,064,053
Investment advisory and management fees2021-12-31$78,852
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$30,816,599
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$26,433,602
Interest earned on other investments2021-12-31$2,223,111
Value of interest in common/collective trusts at end of year2021-12-31$730,305
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31Yes
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$1,232,541
Employer contributions (assets) at end of year2021-12-31$1,232,541
Employer contributions (assets) at beginning of year2021-12-31$1,197,922
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$3,165,033
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32021-12-31No
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31BLACK & PINCKARD LLC
Accountancy firm EIN2021-12-31260079381
2020 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2020 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2020-12-31$3,353,505
Total unrealized appreciation/depreciation of assets2020-12-31$3,353,505
Total income from all sources (including contributions)2020-12-31$6,621,430
Total of all expenses incurred2020-12-31$6,354,023
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$6,268,396
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$2,109,035
Value of total assets at end of year2020-12-31$37,853,208
Value of total assets at beginning of year2020-12-31$37,585,801
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$85,627
Total interest from all sources2020-12-31$1,158,890
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$2,438,454
If this is an individual account plan, was there a blackout period2020-12-31No
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$907,636
Participant contributions at end of year2020-12-31$16,090
Participant contributions at beginning of year2020-12-31$27,029
Assets. Other investments not covered elsewhere at end of year2020-12-31$8,141,541
Assets. Other investments not covered elsewhere at beginning of year2020-12-31$9,910,160
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$267,407
Value of net assets at end of year (total assets less liabilities)2020-12-31$37,853,208
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$37,585,801
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Assets. partnership/joint venture interests at end of year2020-12-31$2,064,053
Assets. partnership/joint venture interests at beginning of year2020-12-31$2,438,454
Investment advisory and management fees2020-12-31$85,627
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$26,433,602
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$24,064,325
Interest earned on other investments2020-12-31$1,158,890
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$1,201,399
Employer contributions (assets) at end of year2020-12-31$1,197,922
Employer contributions (assets) at beginning of year2020-12-31$1,145,833
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$6,268,396
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32020-12-31No
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Disclaimer
Accountancy firm name2020-12-31BLACK & PINCKARD LLC
Accountancy firm EIN2020-12-31260079381
2019 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2019 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2019-12-31$4,679,852
Total unrealized appreciation/depreciation of assets2019-12-31$4,679,852
Total income from all sources (including contributions)2019-12-31$8,036,193
Total of all expenses incurred2019-12-31$1,874,005
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$1,741,102
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$1,966,601
Value of total assets at end of year2019-12-31$37,585,801
Value of total assets at beginning of year2019-12-31$31,423,613
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$132,903
Total interest from all sources2019-12-31$1,384,220
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$820,768
Participant contributions at end of year2019-12-31$27,029
Participant contributions at beginning of year2019-12-31$15,385
Assets. Other investments not covered elsewhere at end of year2019-12-31$789,985
Assets. Other investments not covered elsewhere at beginning of year2019-12-31$768,279
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$6,162,188
Value of net assets at end of year (total assets less liabilities)2019-12-31$37,585,801
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$31,423,613
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Assets. partnership/joint venture interests at end of year2019-12-31$2,438,454
Assets. partnership/joint venture interests at beginning of year2019-12-31$1,567,565
Investment advisory and management fees2019-12-31$132,903
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$28,376,514
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$25,059,117
Interest earned on other investments2019-12-31$1,384,220
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2019-12-31$2,079,349
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2019-12-31$250,730
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2019-12-31$250,730
Asset value of US Government securities at end of year2019-12-31$0
Asset value of US Government securities at beginning of year2019-12-31$51,700
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$5,520
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$1,145,833
Employer contributions (assets) at end of year2019-12-31$1,145,833
Employer contributions (assets) at beginning of year2019-12-31$1,044,609
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$1,741,102
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32019-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2019-12-31$2,728,637
Assets. Corporate common stocks other than exployer securities at beginning of year2019-12-31$2,666,228
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31BLACK & PINCKARD, LLC
Accountancy firm EIN2019-12-31260079381
2018 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2018 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2018-12-31$-3,163,648
Total unrealized appreciation/depreciation of assets2018-12-31$-3,163,648
Total income from all sources (including contributions)2018-12-31$342,968
Total of all expenses incurred2018-12-31$1,126,016
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$1,009,424
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$1,787,370
Value of total assets at end of year2018-12-31$31,423,613
Value of total assets at beginning of year2018-12-31$32,206,661
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$116,592
Total interest from all sources2018-12-31$1,604,955
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$500,000
If this is an individual account plan, was there a blackout period2018-12-31No
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$742,761
Participant contributions at end of year2018-12-31$15,385
Participant contributions at beginning of year2018-12-31$21,331
Assets. Other investments not covered elsewhere at end of year2018-12-31$768,279
Assets. Other investments not covered elsewhere at beginning of year2018-12-31$788,839
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$-783,048
Value of net assets at end of year (total assets less liabilities)2018-12-31$31,423,613
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$32,206,661
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Assets. partnership/joint venture interests at end of year2018-12-31$1,567,565
Assets. partnership/joint venture interests at beginning of year2018-12-31$1,607,656
Investment advisory and management fees2018-12-31$116,592
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$25,059,117
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$25,331,153
Interest earned on other investments2018-12-31$1,604,955
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2018-12-31$250,730
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2018-12-31$117,315
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2018-12-31$117,315
Asset value of US Government securities at end of year2018-12-31$51,700
Asset value of US Government securities at beginning of year2018-12-31$71,407
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$114,291
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$1,044,609
Employer contributions (assets) at end of year2018-12-31$1,044,609
Employer contributions (assets) at beginning of year2018-12-31$979,353
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$1,009,424
Asset. Corporate debt instrument debt (other) at end of year2018-12-31$0
Asset. Corporate debt instrument debt (other) at beginning of year2018-12-31$81,227
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32018-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2018-12-31$2,666,228
Assets. Corporate common stocks other than exployer securities at beginning of year2018-12-31$3,208,380
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31BLACK & PINCKARD, LLC
Accountancy firm EIN2018-12-31260079381
2017 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2017 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2017-12-31$3,264,049
Total unrealized appreciation/depreciation of assets2017-12-31$3,264,049
Total income from all sources (including contributions)2017-12-31$6,504,772
Total of all expenses incurred2017-12-31$3,199,856
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$3,091,330
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$1,680,803
Value of total assets at end of year2017-12-31$32,206,661
Value of total assets at beginning of year2017-12-31$28,901,745
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$108,526
Total interest from all sources2017-12-31$1,272,853
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$500,000
If this is an individual account plan, was there a blackout period2017-12-31No
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$701,381
Participant contributions at end of year2017-12-31$21,331
Participant contributions at beginning of year2017-12-31$24,456
Assets. Other investments not covered elsewhere at end of year2017-12-31$788,839
Assets. Other investments not covered elsewhere at beginning of year2017-12-31$1,673,267
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$3,304,916
Value of net assets at end of year (total assets less liabilities)2017-12-31$32,206,661
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$28,901,745
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Assets. partnership/joint venture interests at end of year2017-12-31$1,607,656
Assets. partnership/joint venture interests at beginning of year2017-12-31$2,388,514
Investment advisory and management fees2017-12-31$108,526
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$25,331,153
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$20,215,846
Interest earned on other investments2017-12-31$1,272,853
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2017-12-31$117,315
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2017-12-31$159,146
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2017-12-31$159,146
Asset value of US Government securities at end of year2017-12-31$71,407
Asset value of US Government securities at beginning of year2017-12-31$67,321
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$287,067
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$979,422
Employer contributions (assets) at end of year2017-12-31$979,353
Employer contributions (assets) at beginning of year2017-12-31$905,857
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$3,091,330
Asset. Corporate debt instrument debt (other) at end of year2017-12-31$81,227
Asset. Corporate debt instrument debt (other) at beginning of year2017-12-31$74,565
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32017-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2017-12-31$3,208,380
Assets. Corporate common stocks other than exployer securities at beginning of year2017-12-31$3,392,773
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31BLACK & PINCKARD, LLC
Accountancy firm EIN2017-12-31260079381
2016 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2016 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2016-12-31$1,160,601
Total unrealized appreciation/depreciation of assets2016-12-31$1,160,601
Total income from all sources (including contributions)2016-12-31$3,592,170
Total of all expenses incurred2016-12-31$2,405,448
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$2,307,931
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$1,673,010
Value of total assets at end of year2016-12-31$28,901,745
Value of total assets at beginning of year2016-12-31$27,715,023
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$97,517
Total interest from all sources2016-12-31$746,397
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$500,000
If this is an individual account plan, was there a blackout period2016-12-31No
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$628,962
Participant contributions at end of year2016-12-31$24,456
Participant contributions at beginning of year2016-12-31$17,957
Assets. Other investments not covered elsewhere at end of year2016-12-31$1,673,267
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$138,191
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$1,186,722
Value of net assets at end of year (total assets less liabilities)2016-12-31$28,901,745
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$27,715,023
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Assets. partnership/joint venture interests at end of year2016-12-31$2,388,514
Assets. partnership/joint venture interests at beginning of year2016-12-31$2,265,093
Investment advisory and management fees2016-12-31$97,517
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$20,215,846
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$19,105,807
Interest earned on other investments2016-12-31$746,397
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2016-12-31$159,146
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2016-12-31$381,886
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2016-12-31$381,886
Asset value of US Government securities at end of year2016-12-31$67,321
Asset value of US Government securities at beginning of year2016-12-31$189,324
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$12,162
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$905,857
Employer contributions (assets) at end of year2016-12-31$905,857
Employer contributions (assets) at beginning of year2016-12-31$855,187
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$2,307,931
Asset. Corporate debt instrument debt (other) at end of year2016-12-31$74,565
Asset. Corporate debt instrument debt (other) at beginning of year2016-12-31$252,820
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32016-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2016-12-31$3,392,773
Assets. Corporate common stocks other than exployer securities at beginning of year2016-12-31$4,646,949
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31BLACK & PINCKARD, LLC
Accountancy firm EIN2016-12-31260079381
2015 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2015 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2015-12-31$-282,225
Total unrealized appreciation/depreciation of assets2015-12-31$-282,225
Total income from all sources (including contributions)2015-12-31$2,148,171
Total of all expenses incurred2015-12-31$717,238
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$605,128
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$1,446,987
Value of total assets at end of year2015-12-31$27,715,023
Value of total assets at beginning of year2015-12-31$26,284,090
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$112,110
Total interest from all sources2015-12-31$1,061,404
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$500,000
If this is an individual account plan, was there a blackout period2015-12-31No
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$591,800
Participant contributions at beginning of year2015-12-31$77
Participant contributions at end of year2015-12-31$17,957
Participant contributions at beginning of year2015-12-31$15,965
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$1,430,933
Value of net assets at end of year (total assets less liabilities)2015-12-31$27,715,023
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$26,284,090
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Assets. partnership/joint venture interests at end of year2015-12-31$2,265,093
Assets. partnership/joint venture interests at beginning of year2015-12-31$1,431,657
Investment advisory and management fees2015-12-31$112,110
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$19,105,807
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$18,420,039
Interest earned on other investments2015-12-31$1,061,404
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2015-12-31$381,886
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2015-12-31$710,514
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2015-12-31$710,514
Asset value of US Government securities at end of year2015-12-31$189,324
Asset value of US Government securities at beginning of year2015-12-31$190,939
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-77,995
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$855,187
Employer contributions (assets) at end of year2015-12-31$855,187
Employer contributions (assets) at beginning of year2015-12-31$814,010
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$605,128
Asset. Corporate debt instrument debt (other) at end of year2015-12-31$252,820
Asset. Corporate debt instrument debt (other) at beginning of year2015-12-31$310,518
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32015-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2015-12-31$4,646,949
Assets. Corporate common stocks other than exployer securities at beginning of year2015-12-31$4,390,371
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31PEARCE BEVILL LEESBURG MOORE PC
Accountancy firm EIN2015-12-31630813240
2014 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2014 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2014-12-31$1,417,823
Total unrealized appreciation/depreciation of assets2014-12-31$1,417,823
Total income from all sources (including contributions)2014-12-31$3,069,331
Total of all expenses incurred2014-12-31$364,223
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$239,162
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$1,417,619
Value of total assets at end of year2014-12-31$26,284,090
Value of total assets at beginning of year2014-12-31$23,578,982
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$125,061
Total interest from all sources2014-12-31$223,489
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$500,000
If this is an individual account plan, was there a blackout period2014-12-31No
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$603,608
Participant contributions at end of year2014-12-31$77
Participant contributions at beginning of year2014-12-31$3,026
Participant contributions at end of year2014-12-31$15,965
Participant contributions at beginning of year2014-12-31$14,628
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$2,705,108
Value of net assets at end of year (total assets less liabilities)2014-12-31$26,284,090
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$23,578,982
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Assets. partnership/joint venture interests at end of year2014-12-31$111,677
Assets. partnership/joint venture interests at beginning of year2014-12-31$549,614
Investment advisory and management fees2014-12-31$125,061
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$18,420,039
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$15,647,297
Interest on participant loans2014-12-31$43
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2014-12-31$710,514
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2014-12-31$917,194
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2014-12-31$917,194
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2014-12-31$223,446
Asset value of US Government securities at end of year2014-12-31$190,939
Asset value of US Government securities at beginning of year2014-12-31$906,574
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$10,400
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$814,011
Employer contributions (assets) at end of year2014-12-31$814,010
Employer contributions (assets) at beginning of year2014-12-31$777,848
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$239,162
Asset. Corporate debt instrument debt (other) at end of year2014-12-31$310,518
Asset. Corporate debt instrument debt (other) at beginning of year2014-12-31$266,116
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32014-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2014-12-31$5,710,351
Assets. Corporate common stocks other than exployer securities at beginning of year2014-12-31$4,496,685
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31PEARCE BEVILL LEESBURG MOORE PC
Accountancy firm EIN2014-12-31630813240
2013 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2013 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2013-12-31$2,320,716
Total unrealized appreciation/depreciation of assets2013-12-31$2,320,716
Total income from all sources (including contributions)2013-12-31$4,181,597
Total of all expenses incurred2013-12-31$128,694
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$8,947
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$1,337,561
Value of total assets at end of year2013-12-31$23,578,982
Value of total assets at beginning of year2013-12-31$19,526,079
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$119,747
Total interest from all sources2013-12-31$513,248
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$500,000
If this is an individual account plan, was there a blackout period2013-12-31No
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$546,492
Participant contributions at end of year2013-12-31$3,026
Participant contributions at beginning of year2013-12-31$11,551
Participant contributions at end of year2013-12-31$14,628
Participant contributions at beginning of year2013-12-31$9,854
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$13,221
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$4,052,903
Value of net assets at end of year (total assets less liabilities)2013-12-31$23,578,982
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$19,526,079
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Assets. partnership/joint venture interests at end of year2013-12-31$549,614
Assets. partnership/joint venture interests at beginning of year2013-12-31$1,741,573
Investment advisory and management fees2013-12-31$119,747
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$15,647,297
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$12,714,685
Interest on participant loans2013-12-31$292
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2013-12-31$917,194
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2013-12-31$583,107
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2013-12-31$583,107
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2013-12-31$512,956
Asset value of US Government securities at end of year2013-12-31$906,574
Asset value of US Government securities at beginning of year2013-12-31$216,721
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$10,072
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$777,848
Employer contributions (assets) at end of year2013-12-31$777,848
Employer contributions (assets) at beginning of year2013-12-31$717,622
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$8,947
Asset. Corporate debt instrument debt (other) at end of year2013-12-31$266,116
Asset. Corporate debt instrument debt (other) at beginning of year2013-12-31$138,492
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32013-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2013-12-31$4,496,685
Assets. Corporate common stocks other than exployer securities at beginning of year2013-12-31$3,392,474
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31No
Opinion of an independent qualified public accountant for this plan2013-12-31Unqualified
Accountancy firm name2013-12-31PEARCE BEVILL LEESBURG MOORE, PC
Accountancy firm EIN2013-12-31630813240
2012 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2012 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2012-12-31$1,536,481
Total unrealized appreciation/depreciation of assets2012-12-31$1,536,481
Total income from all sources (including contributions)2012-12-31$3,265,332
Total of all expenses incurred2012-12-31$738,742
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$670,703
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$1,263,934
Value of total assets at end of year2012-12-31$19,526,079
Value of total assets at beginning of year2012-12-31$16,999,489
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$68,039
Total interest from all sources2012-12-31$379,359
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$500,000
If this is an individual account plan, was there a blackout period2012-12-31No
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$508,968
Participant contributions at end of year2012-12-31$11,551
Participant contributions at beginning of year2012-12-31$21,906
Participant contributions at end of year2012-12-31$9,854
Participant contributions at beginning of year2012-12-31$11,325
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$13,206
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$2,526,590
Value of net assets at end of year (total assets less liabilities)2012-12-31$19,526,079
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$16,999,489
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Assets. partnership/joint venture interests at end of year2012-12-31$1,741,573
Assets. partnership/joint venture interests at beginning of year2012-12-31$1,106,245
Investment advisory and management fees2012-12-31$68,039
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$12,714,685
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$10,626,642
Interest on participant loans2012-12-31$773
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2012-12-31$583,107
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2012-12-31$1,221,707
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2012-12-31$1,221,707
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2012-12-31$378,586
Asset value of US Government securities at end of year2012-12-31$216,721
Asset value of US Government securities at beginning of year2012-12-31$249,106
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$85,558
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$741,760
Employer contributions (assets) at end of year2012-12-31$717,622
Employer contributions (assets) at beginning of year2012-12-31$742,866
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$670,703
Asset. Corporate debt instrument debt (other) at end of year2012-12-31$138,492
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32012-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2012-12-31$3,392,474
Assets. Corporate common stocks other than exployer securities at beginning of year2012-12-31$3,019,692
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31No
Opinion of an independent qualified public accountant for this plan2012-12-31Unqualified
Accountancy firm name2012-12-31PEARCE, BEVILL, LEESBURG, MOORE, PC
Accountancy firm EIN2012-12-31630813240
2011 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2011 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2011-12-31$-169,458
Total unrealized appreciation/depreciation of assets2011-12-31$-169,458
Total income from all sources (including contributions)2011-12-31$1,341,352
Total of all expenses incurred2011-12-31$598,410
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$577,466
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$1,249,061
Value of total assets at end of year2011-12-31$16,999,489
Value of total assets at beginning of year2011-12-31$16,256,547
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$20,944
Total interest from all sources2011-12-31$260,556
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$500,000
If this is an individual account plan, was there a blackout period2011-12-31No
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$507,206
Participant contributions at end of year2011-12-31$21,906
Participant contributions at beginning of year2011-12-31$33,072
Participant contributions at end of year2011-12-31$11,325
Participant contributions at beginning of year2011-12-31$15,411
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$742,942
Value of net assets at end of year (total assets less liabilities)2011-12-31$16,999,489
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$16,256,547
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Assets. partnership/joint venture interests at end of year2011-12-31$1,106,245
Assets. partnership/joint venture interests at beginning of year2011-12-31$1,470,910
Investment advisory and management fees2011-12-31$20,944
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$10,626,642
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$10,099,174
Interest on participant loans2011-12-31$1,351
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2011-12-31$1,221,707
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2011-12-31$252,461
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2011-12-31$252,461
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2011-12-31$259,205
Asset value of US Government securities at end of year2011-12-31$249,106
Asset value of US Government securities at beginning of year2011-12-31$222,566
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$1,193
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31No
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$741,855
Employer contributions (assets) at end of year2011-12-31$742,866
Employer contributions (assets) at beginning of year2011-12-31$704,592
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$577,466
Asset. Corporate debt instrument debt (other) at beginning of year2011-12-31$102,724
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32011-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2011-12-31$3,019,692
Assets. Corporate common stocks other than exployer securities at beginning of year2011-12-31$3,355,637
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31No
Opinion of an independent qualified public accountant for this plan2011-12-31Unqualified
Accountancy firm name2011-12-31PEARCE BEVILL LEESBURG MOORE, PC
Accountancy firm EIN2011-12-31630813240
2010 : BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2010 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets2010-12-31$1,846,839
Total unrealized appreciation/depreciation of assets2010-12-31$1,846,839
Total income from all sources (including contributions)2010-12-31$3,353,002
Total of all expenses incurred2010-12-31$77,815
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$58,236
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$1,197,426
Value of total assets at end of year2010-12-31$16,256,547
Value of total assets at beginning of year2010-12-31$12,981,360
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$19,579
Total interest from all sources2010-12-31$270,704
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$500,000
If this is an individual account plan, was there a blackout period2010-12-31No
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$492,834
Participant contributions at end of year2010-12-31$33,072
Participant contributions at beginning of year2010-12-31$49,935
Participant contributions at end of year2010-12-31$15,411
Participant contributions at beginning of year2010-12-31$10,472
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$3,275,187
Value of net assets at end of year (total assets less liabilities)2010-12-31$16,256,547
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$12,981,360
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Assets. partnership/joint venture interests at end of year2010-12-31$1,470,910
Assets. partnership/joint venture interests at beginning of year2010-12-31$1,427,211
Investment advisory and management fees2010-12-31$19,579
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$10,099,174
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$8,035,905
Interest on participant loans2010-12-31$2,069
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2010-12-31$252,461
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2010-12-31$252,135
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2010-12-31$252,135
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2010-12-31$268,635
Asset value of US Government securities at end of year2010-12-31$222,566
Asset value of US Government securities at beginning of year2010-12-31$209,300
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$38,033
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31No
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$704,592
Employer contributions (assets) at end of year2010-12-31$704,592
Employer contributions (assets) at beginning of year2010-12-31$668,309
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$58,236
Asset. Corporate debt instrument debt (other) at end of year2010-12-31$102,724
Asset. Corporate debt instrument debt (other) at beginning of year2010-12-31$80,312
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32010-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2010-12-31$3,355,637
Assets. Corporate common stocks other than exployer securities at beginning of year2010-12-31$2,247,781
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31Yes
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31No
Opinion of an independent qualified public accountant for this plan2010-12-31Unqualified
Accountancy firm name2010-12-31PEARCE BEVILL LEESBURG MOORE, PC
Accountancy firm EIN2010-12-31630813240

Form 5500 Responses for BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN

2022: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement - TrustYes
2021: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement - TrustYes
2020: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement - TrustYes
2019: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement - TrustYes
2018: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement - TrustYes
2017: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement - TrustYes
2016: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement - TrustYes
2015: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes
2012: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2009: BIRMINGHAM HEMATOLOGY & ONCOLOGY ASSOCIATES, LLC 401K PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedYes
2009-01-01This submission is the final filingNo
2009-01-01Plan funding arrangement – InsuranceYes
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement – InsuranceYes
2009-01-01Plan benefit arrangement - TrustYes

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3